CyclophosphamideEpirubicinAntineoplastic Combined Chemotherapy ProtocolsAntibiotics, AntineoplasticBreast NeoplasmsFluorouracilDoxorubicinDrug Administration SchedulePaclitaxelVincristineChemotherapy, AdjuvantTaxoidsTreatment OutcomeAntineoplastic Agents, AlkylatingMethotrexateGranulocyte Colony-Stimulating FactorDisease-Free SurvivalRazoxaneCisplatinPhosphoramide MustardsPrednisoneCombined Modality TherapyNeoadjuvant TherapyEtoposideInfusions, IntravenousSurvival AnalysisDose-Response Relationship, DrugAnthracyclinesSurvival RateLeukopeniaVinblastineNeutropeniaDeoxycytidineIfosfamideAlopeciaThiotepaRemission InductionAntineoplastic AgentsImmunosuppressive AgentsNeoplasm StagingHematologic DiseasesNeoplasm MetastasisPulse Therapy, DrugVomitingTime FactorsNauseaLymphoma, Non-HodgkinCarboplatinFollow-Up StudiesProlyl HydroxylasesMastectomy, RadicalInjections, IntravenousMitoxantroneDrug Therapy, CombinationBusulfanDrug EvaluationPrednisoloneLymphatic MetastasisReceptor, erbB-2Prospective StudiesStomach NeoplasmsHematopoietic Stem Cell TransplantationAdenocarcinomaStomatitisAntibodies, Monoclonal, Murine-Derived